Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 27;18(1):21.
doi: 10.1186/s12876-018-0749-3.

Epidemiology of gastrointestinal symptoms in young and middle-aged Swiss adults: prevalences and comorbidities in a longitudinal population cohort over 28 years

Affiliations

Epidemiology of gastrointestinal symptoms in young and middle-aged Swiss adults: prevalences and comorbidities in a longitudinal population cohort over 28 years

Maria Avramidou et al. BMC Gastroenterol. .

Abstract

Background: Although subacute and chronic gastrointestinal symptoms are very common in primary care, epidemiological date are sparse. The aim of the study was to examine and quantify the prevalence of subacute and chronic gastrointestinal symptoms and their associations with somatic and mental disorders in the general population.

Methods: Data were collected prospectively between 1981 (age m = 22, f = 23) and 2008 (age 49/50) from the Zurich Cohort Study (n = 292 men, 299 women), a representative general population survey. The participants were assessed using a semi-structured interview, the "Structured Psychopathological Interview and Rating of the Social Consequences of Psychological Disturbances for Epidemiology" (SPIKE). Prevalence rates were computed to be representative of the general population aged 22-50. Associations were quantified by odds ratios (ORs) and their 99% confidence intervals (CI).

Results: The prevalences of intestinal and of gastric symptoms were significantly higher among women in all categories examined. For example, any gastric symptoms: f. 26.4% vs m.15.2%; any intestinal symptoms: 27.6% vs 14.6%; nausea/vomitus: 19.1% vs 4.5%; constipation: 15.8% vs 6.5% (all p < 0.001). Strong associations (all p < 0.0001) were found between fatigue (1 month) and chronic stomach (OR = 9.96, 99%-CI: 5.53-17.94) and chronic intestinal symptoms (OR = 9.02, 99%-CI: 4.92-16.54). Panic attacks were associated with subacute intestinal symptoms (OR = 4.00, 99%-CI: 2.43-6.59). Anxiety was more strongly associated with subacute intestinal symptoms (OR = 3.37, 99%-CI: 2.23-5.08) than with subacute stomach symptoms (OR = 1.85, 1.20-2.86). Bipolar disorders were associated with subacute stomach symptoms (OR = 1.83, 1.18-2.17) and unipolar depression with subacute intestinal symptoms (OR = 2.05, 1.34-3.15).

Conclusions: Remarkably high prevalence rates of gastric and intestinal complaints were observed in women (over 1/4; men 1/7). Fatigue/neurasthenia was the strongest co-factor in both conditions. Various syndromes related to anxiety, phobia, and panic disorders showed further significant associations. The integration of psychiatric and/or psychological treatment could help address the functional part of gastric and intestinal syndromes.

Keywords: Associations; Epidemiology; Functional; Gastrointestinal; General population survey; Odds ratios; Prevalence.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. The project received prior approval (1978) from the Ethical Committee of the Zurich University Psychiatric Hospital, University of Zurich, Zurich, Switzerland. Informed consent was obtained from all participants.

Consent for publication

Written informed consent to publish results of the assessed data at congresses and in peer-reviewed journals was obtained from all participants.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Associations with subacute stomach symptoms (n = 76 with, n = 410 without symptoms): Odds ratios (OR), 99% CI, adjusted for sex and education level. Explained variance: 15.7%. Legend: Odds ratios (OR), 99% CI, adjusted for sex and education level
Fig. 2
Fig. 2
Associations with chronic stomach symptoms (n = 54 with, n = 372 without symptoms): Odds ratios (OR), 99% CI, adjusted for sex and education level. Explained variance: 52.4%. Legend: Odds ratios (OR), 99% CI, adjusted for sex and education level
Fig. 3
Fig. 3
Associations with subacute intestinal symptoms (n = 78 with, n = 345 without symptoms): Odds ratios (OR), 99% CI, adjusted for sex and education level. Explained variance: 38.2%. Legend: Odds ratios (OR), 99% CI, adjusted for sex and education level
Fig. 4
Fig. 4
Associations with chronic intestinal symptoms (n = 76 with, n = 345 without symptoms): Odds ratios (OR), 99% CI, adjusted for sex and education level. Explained variance: 45.7%. Legend: Odds ratios (OR), 99% CI, adjusted for sex and education level

References

    1. Smith ER. Epidemiology of gastrointestinal disorders. Can Fam Phys. 1978;24:1007–1011. - PMC - PubMed
    1. Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterol. 2012;143(5):1179–1187. doi: 10.1053/j.gastro.2012.08.002. - DOI - PMC - PubMed
    1. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet. 1999;354(9182):936–939. doi: 10.1016/S0140-6736(98)08320-2. - DOI - PubMed
    1. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet. 2007;369(9565):946–955. doi: 10.1016/S0140-6736(07)60159-7. - DOI - PubMed
    1. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther. 2003;17(5):643–650. doi: 10.1046/j.1365-2036.2003.01456.x. - DOI - PubMed